Outcome of Regenerative Endodontic Procedures

Sponsor
King Abdullah University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05612451
Collaborator
(none)
45
1
2
75.3
0.6

Study Details

Study Description

Brief Summary

Clinical management of immature non-vital (necrotic) permanent teeth is challenging, due to inherent structural weakness. Earlier management of such teeth relied on the traditional calcium hydroxide (Ca(OH)2) apexification procedure or the application of apical barriers However, neither procedure allows for promoting root dentin maturation. In 2004, a novel management technique for treating immature, non-vital teeth called regenerative endodontic procedures (REP; also known as revascularization) was introduced. This procedure allowed for continued root maturation presented in an increase in root length and dentin wall thickness. The key points of REP include minimal or no instrumentation of the dentinal walls, disinfection with irrigant solutions and intracanal medicaments, provocation of bleeding into the canal space for creation of a blood clot, capping with calcium silicate-based material, and an effective coronal seal to prevent reinfection of the root canal system. Several case reports and clinical studies reported promising results for REP treatment. However, studies widely varied in their treatment methods, hence the search for an optimal REP protocol is still ongoing. A recent review reported that the methodological quality of REP clinical trials available to date, was low with a moderate to high risk of bias. To date, only few studies evaluated the outcome of REPs based on different types of intracanal medicaments. These studies either presented a retrospective design, low sample size and/or short follow up period. Hence, the need for randomized, controlled clinical studies to provide persuasive evidence on the efficacy of different intracanal medicaments in REP is of utmost importance. The aim of this study is to prospectively assess and compare the clinical and radiographic outcomes of REP in non-vital immature permanent teeth using an intracanal medicament modified TAP or non-setting Ca(OH)2 paste. Forty-five patients yielding a total of 50 anterior and posterior non-vital immature teeth were randomly divided into 2 groups. REP utilizing either non-setting calcium hydroxide (Ca(OH)2) (n=25) or modified triple antibiotic paste (TAP) (n=25), as intracanal medicaments were performed. NeoMTA Plus was applied for coronal sealing. Cases were followed up clinically and radiographically for 24 months. Survival rate, success rate, and clinical outcome measures were analyzed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Regenerative Endodontic Procedures
  • Other: non-setting calcium hydroxide
  • Other: modified triple antibiotic paste
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This randomized clinical trial aimed to assess and compare the clinical and radiographic outcomes of Regenerative Endodontic Procedures (REP) in treating non-vital immature permanent teeth using two intracanal medicaments.This randomized clinical trial aimed to assess and compare the clinical and radiographic outcomes of Regenerative Endodontic Procedures (REP) in treating non-vital immature permanent teeth using two intracanal medicaments.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outcome of Regenerative Endodontic Procedures for Necrotic Immature Permanent Teeth, Using Two Different Protocols: A Prospective Randomized Clinical Study.
Actual Study Start Date :
Mar 20, 2018
Actual Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Jun 27, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: non-setting calcium hydroxide

Regenerative Endodontic Procedure utilizing non-setting calcium hydroxide as intracanal medicament

Procedure: Regenerative Endodontic Procedures
Regenerative Endodontic procedures were performed by one operator following similar protocols according to the clinical considerations for a regenerative procedure advised by the American Association of Endodontists and European Society of Endodontology

Other: non-setting calcium hydroxide
non-setting calcium hydroxide

Experimental: modified triple antibiotic paste

Regenerative Endodontic Procedure utilizing modified triple antibiotic paste as intracanal medicament

Procedure: Regenerative Endodontic Procedures
Regenerative Endodontic procedures were performed by one operator following similar protocols according to the clinical considerations for a regenerative procedure advised by the American Association of Endodontists and European Society of Endodontology

Other: modified triple antibiotic paste
modified triple antibiotic paste

Outcome Measures

Primary Outcome Measures

  1. treatment success [36 months]

    disappearance of clinical signs and symptoms including tenderness to percussion or palpation, a swelling or sinus tract, or spontaneous pain, and absence or reduction in the size of periapiacl radiolucency

Secondary Outcome Measures

  1. root elongation [36 months]

    increased root length

  2. root maturation [36 months]

    increased root dentin thickness

  3. root completion [36 months]

    apical closure

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Anterior or posterior tooth diagnosed with necrotic pulp (as a result of trauma, caries or anomaly) in the presence or absence of apical periodontitis.

  2. an immature apex or open apex(an apical diameter wider than 1 mm and is radiographically visible)

  3. Pulp space not needed for post and core restoration

  4. A cooperative and Compliant patient/ parent

  5. Patients not allergic to medicaments necessary to complete the procedure.

Exclusion Criteria:
  1. medically compromised patient,

  2. teeth with vertical fractures,

  3. periodontally involved teeth,

  4. non-restorable teeth,

  5. teeth when bleeding could not be induced.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jordan University of Science & Technology Irbid Jordan 22110

Sponsors and Collaborators

  • King Abdullah University Hospital

Investigators

  • Principal Investigator: Aladdin A Al-Qudah, PhD, Jordan University of Science & Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
King Abdullah University Hospital
ClinicalTrials.gov Identifier:
NCT05612451
Other Study ID Numbers:
  • 20180112
First Posted:
Nov 10, 2022
Last Update Posted:
Nov 10, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by King Abdullah University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2022